Valuation: hVIVO plc

Market Cap 34.69M 45.88M 41.57M 38.45M 65.38M 4.33B 67.69M 462M 183M 2.31B 172M 169M 7.33B P/E 2026 *
-5.03x
P/E 2027 * -24x
Enterprise Value 39.24M 51.89M 47.02M 43.49M 73.96M 4.89B 76.56M 522M 207M 2.61B 195M 191M 8.3B EV / Sales 2026 *
0.83x
EV / Sales 2027 * 0.61x
Free-Float
96.89%
Yield 2026 *
-
Yield 2027 * 1.54%
1 day-2.88%
1 week-3.81%
Current month-15.83%
1 month-14.41%
3 months-22.90%
6 months-32.21%
Current year-19.84%
1 week 4.8
Extreme 4.8
5.4
1 month 4.8
Extreme 4.8
6.3
Current year 4.8
Extreme 4.8
11
1 year 4.3
Extreme 4.305
11
3 years 4.3
Extreme 4.305
32
5 years 4.3
Extreme 4.305
32
10 years 4.3
Extreme 4.305
48
Manager TitleAgeSince
Chief Executive Officer 57 24/02/2022
Corporate Officer/Principal 39 01/07/2017
Director of Finance/CFO 65 30/09/2026
Director TitleAgeSince
Director/Board Member 57 13/10/2021
Chairman 59 01/09/2025
Director/Board Member 65 18/12/2025
Date Insider Type Main position Quantity % Market Cap. Importance
28/05/26 Free

Chief Financial Officer

2,289,604 0.3326%
28/05/26 Free

Chief Executive Officer

6,126,238 0.8899%
24/04/26 Sell

Founder

2,017,000 0.2930%
Change 5-day change 1-year change 3-year change Capi.($)
-2.88%-3.81%-20.47%-73.70% 45.88M
-2.69%-0.48%+53.97%+70.99% 66.33B
-0.92%+7.67%+12.64%+92.55% 60.62B
0.00%+0.39%+22.34%+90.83% 55.5B
+0.14%+2.35%+13.86%+106.64% 47.58B
-2.21%-2.47%+20.18%+32.24% 43.69B
-2.30%-10.40%+154.30%+725.54% 37.27B
+2.15%+1.42%+14.58%+54.23% 36.57B
-2.32%-2.24%+76.50%+54.55% 32.22B
+2.62%+5.90%-37.29%+393.72% 26.58B
Average -0.84%-0.34%+31.06%+154.76% 41B
Weighted average by Cap. -0.83%+0.20%+36.62%+155.22%

Financials

2026 *2027 *
Net sales 47.02M 62.18M 56.35M 52.12M 88.62M 5.86B 91.74M 626M 248M 3.13B 233M 228M 9.94B 56.9M 75.24M 68.18M 63.06M 107M 7.09B 111M 758M 300M 3.79B 282M 276M 12.03B
Net income -6.47M -8.56M -7.76M -7.17M -12.2M -807M -12.63M -86.18M -34.17M -431M -32.12M -31.44M -1.37B -1.89M -2.5M -2.27M -2.1M -3.56M -236M -3.69M -25.17M -9.98M -126M -9.38M -9.18M -400M
Net Debt 4.55M 6.02M 5.45M 5.04M 8.57M 567M 8.88M 60.57M 24.02M 303M 22.57M 22.1M 962M 255K 337K 305K 282K 480K 31.76M 497K 3.39M 1.34M 16.97M 1.26M 1.24M 53.85M
Projected Income Statement - Annual - hVIVO plc
Logo hVIVO plc
hVIVO plc is a United Kingdom-based purpose-built, full-service international clinical development partner and engaged in human challenge trials serving biopharma companies. The Company has an end-to-end platform designed to bring important medicines to patients faster: spanning preclinical strategy, first in human studies, Phase II patient trials and specialist laboratory services, delivered through a participant database, wholly owned sites and laboratories across the UK and Germany. The Company offers integrated service lines which include consulting, clinical trials, human challenge trials, and laboratories. Its consulting provides preclinical and clinical strategy, encompassing non-clinical, clinical, CMC, pharmacokinetics, data management, biostatistics, and regulatory support to guide trial design, execution, and interpretation. The Company is also focused on Phase I/II clinical studies, particularly in dermatology and women's health.
Employees
376
Date Price Change Volume
13/11/26 GBX 5.050 -2.88% 761,157
12/11/26 GBX 5.200 +2.36% 1,069,235
11/11/26 GBX 5.080 +1.60% 1,415,557
10/11/26 GBX 5.000 -1.96% 3,735,893
09/11/26 GBX 5.100 -2.86% 1,360,300
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - hVIVO plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
0.0505GBP
Average target price
0.1550GBP
Spread / Average Target
+206.93%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - hVIVO plc
  1. Stock Market
  2. Stocks
  3. VENN Stock